IP Library Granted Patent US 7,678,915
Granted Patent B2
US 7,678,915 · App. 11/521,820 · Granted Mar 16, 2010

Process for production of piperidine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,915
App. No.
11/521,820
Granted
Mar 16, 2010
Kind
B2
Abstract

The present invention relates to a process for preparing piperidine derivative compounds of the formulae: wherein n is 0 or 1; R 1 is hydrogen or hydroxy; R 2 is hydrogen; or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen; R 3 is —COOH or —COOR 4 ; R 4 is an alkyl or aryl moiety; A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents, The process comprises providing a regiosomer of the following formula: m is an integer from 1 to 6; Q and Y are the same or different and are selected from the group consisting of O, S, and NR 5 ; G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ; R 6 and R 7 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, an aryl moiety, OR 8 , SR 8 , and NR 8 R 9 ; and R 5 , R 8 , and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety and converting the regioisomer to the piperidine derivative compound with a piperidine compound.

Claims (222)

1. A process of preparing a piperidine derivative compound of the formula I or II:

wherein

n is 0 or 1;

R 1 is hydrogen or hydroxy;

R 2 is hydrogen;

or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen;

R 3 is —COOH or —COOR 4 ;

R 4 is an alkyl or aryl moiety;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents;

said process comprising:

providing a regioisomer of the following formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ; and

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety and

converting the regioisomer to the piperidine derivative compound of formula I or II with a piperidine compound of formula III

2. A process according to claim 1 , wherein said providing the regioisomer comprises:

acylating an α-α-disubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formula:

wherein

X 2 is a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the regioisomer.

3. A process according to claim 2 further comprising:

reacting an α-α-diunsubstituted-methylbenzene derivative having the formula:

with a methylating agent under conditions effective to produce the α-α-disubstituted-methylbenzene derivative.

4. A process according to claim 1 , wherein said providing the regioisomer comprises:

reacting a 4-(α-α-disubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the regioisomer.

5. A process according to claim 4 , further comprising:

reacting a 4-(α-α-diunsubstituted)-toluic acid derivative having the formula:

with a methylating agent under conditions effective to produce the 4-(α-α-disubstituted)-toluic acid derivative.

6. A process according to claim 1 , wherein said providing the regioisomer comprises:

providing an α-α-diunsubstituted regioisomer precursor having the formula:

and

methylating the α-α-diunsubstituted regioisomer precursor under conditions effective to produce the regioisomer.

7. A process according to claim 6 , wherein said providing the α-α-diunsubstituted regioisomer precursor comprises:

acylating an α-α-diunsubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formula:

wherein

X 2 is a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the α-α-diunsubstituted regioisomer precursor.

8. A process according to claim 6 , wherein said providing the α-α-diunsubstituted regioisomer precursor comprises:

reacting a 4-(α-α-diunsubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the α-α-diunsubstituted regioisomer precursor.

9. A process according to claim 1 , further comprising:

reducing the piperidine derivative compound of formula I under conditions effective to form the piperidine derivative compound of formula II:

10. A process according to claim 9 , wherein the piperidine derivative compound of formula II is:

11. A process according to claim 9 , wherein the piperidine derivative compound of formula II is:

12. A process according to claim 1 , wherein the piperidine derivative compound of formula I is:

13. A process according to claim 1 , wherein the piperidine derivative compound of formula I is:

14. A process according to claim 1 , wherein said converting comprises:

halogenating the regioisomer of the formula:

under conditions effective to form a first intermediate compound of the formula:

wherein X 3 is a halogen or a hydroxy, alkoxy, or aryloxy moiety.

15. A process according to claim 14 , wherein said halogenating comprises sequentially:

decyclizing the regioisomer to produce an oxobutyl derivative having the formula:

and then

converting the oxobutyl derivative to the first intermediate compound.

16. A process according to claim 14 , wherein said converting further comprises:

reacting the first intermediate compound with the piperidine compound of formula III:

under conditions effective to form a piperidine derivative compound of formula IV:

17. A process according to claim 14 , wherein said converting further comprises:

esterifying the first intermediate compound to the ester thereof, having the formula:

and

reacting the ester with the piperidine compound of formula III:

under conditions effective to form a piperidine derivative compound of formula V:

18. A process according to claim 17 , further comprising:

hydrolyzing the piperidine derivative compound of formula V:

to the piperidine derivative compound of formula IV:

19. A process according to claim 14 , wherein n is 1 and wherein said converting further comprises:

reacting the first intermediate compound with 4-hydroxypiperidine under conditions effective to produce an N-substituted hydroxypiperidine having the formula:

and

reacting the N-substituted hydroxypiperidine with a diarylhalomethane having the formula:

wherein X 4 is a halogen

under conditions effective to form a piperidine compound derivative of formula VI:

20. A process according to claim 1 , wherein said converting comprises:

decyclizing the regioisomer of the formula:

under conditions effective to form an oxobutyl derivative of the formula:

wherein X 3 is a halogen or a hydroxy, alkoxy, or aryloxy moiety.

21. A process according to claim 20 , wherein said converting further comprises:

reacting the oxobutyl derivative with the piperidine compound of formula III:

under conditions effective to form the piperidine derivative precursor of the formula:

22. A process according to claim 21 , further comprising

converting the piperidine derivative precursor to the piperidine derivative compound of formula IV:

23. A process according to claim 21 , further comprising

reducing the piperidine derivative precursor under conditions effective to form a hydroxylated piperidine derivative precursor of the formula:

24. A process according to claim 23 , further comprising

converting the hydroxylated piperidine derivative precursor to a piperidine derivative compound of formula VII:

25. A process according to claim 20 , wherein n is 1 and wherein said converting further comprises:

reacting the oxobutyl derivative with 4-hydroxypiperidine under conditions effective to produce an N-substituted-hydroxypiperidine having the formula:

and

reacting the N-substituted hydroxypiperidine with a diarylhalomethane having the formula:

wherein X 4 is a halogen

under conditions effective to form the piperidine derivative precursor of the formula:

26. A process according to claim 25 , further comprising

converting the piperidine derivative precursor to the piperidine derivative compound of formula IV:

27. A process according to claim 25 , further comprising

reducing the piperidine derivative precursor under conditions effective to form a hydroxylated piperidine derivative precursor of the formula:

28. A process according to claim 27 , further comprising

converting the hydroxylated piperidine derivative precursor to the piperidine derivative compound of formula VIII:

29. A regioisomer having the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents.

30. A process of preparing a regioisomer of the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents,

said process comprising

acylating an α-α-disubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formula:

wherein

X 2 is a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the regioisomer.

31. A process according to claim 30 further comprising:

reacting an α-α-diunsubstituted-methylbenzene derivative having the formula:

with a methylating agent under conditions effective to produce the α-α-disubstituted-methylbenzene derivative.

32. A process of preparing a regioisomer of the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents,

said process comprising:

reacting a 4-(α-α-disubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the regioisomer.

33. A process according to claim 32 further comprising:

reacting a 4-(α-α-diunsubstituted)-toluic acid derivative having the formula:

with a methylating agent under conditions effective to produce the 4-(α-α-disubstituted)-toluic acid derivative.

34. A process of preparing a regioisomer of the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents,

said process comprising:

providing an α-α-diunsubstituted regioisomer precursor having the formula:

and

methylating the α-α-diunsubstituted regioisomer precursor under conditions effective to produce the regioisomer.

35. A process according to claim 34 , wherein said providing the α-α-diunsubstituted regioisomer precursor comprises:

acylating an α-α-diunsubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formula:

wherein

X 2 is a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the α-α-diunsubstituted regioisomer precursor.

36. A process according to claim 35 , wherein said providing the α-α-diunsubstituted regioisomer precursor comprises:

acylating a 4-(α-α-diunsubstituted)-toluic acid derivative having the formula:

wherein

X 2 is a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the α-α-diunsubstituted regioisomer precursor.

37. An α-α-disubstituted-methylbenzene derivative having the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety,

with a proviso that when G 1 , G 2 , and G 3 are OR 8 , R 8 is not an alkyl moiety;

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents; and

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions.

38. An α-α-diunsubstituted-methylbenzene derivative having the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety,

with a proviso that when G 1 , G 2 , and G 3 are OR 8 , R 8 is not an alkyl moiety;

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents; and

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions.

39. An oxobutyl derivative having the formula:

wherein

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety,

with a proviso that when G 1 , G 2 , and G 3 are OR 8 , R 8 is not an alkyl moiety;

A is the substituents of its ring, each of which may be different or the same and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents; and

X 3 is a halogen or a hydroxy, alkoxy, or aryloxy moiety.

40. A piperidine derivative precursor having the formulae:

wherein

n is 0 or 1;

R 1 is hydrogen or hydroxy;

R 2 is hydrogen;

or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen;

Z is -CG 1 G 2 G 3 ,

G 1 , G 2 , and G 3 are the same or different and are selected from the group consisting of OR 8 , SR 8 , and NR 8 R 9 ;

R 8 and R 9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety; and

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents.

Assignments (14)
ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON SEPTEMBER 1, 2017, AT REEL/FRAME 043746/0621 Recorded Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
SECURITY INTEREST Recorded Sep 6, 2021
From: CURIA GLOBAL, INC. (FKA ALBANY MOLECULAR RESEARCH, INC.); CURIA MASSACHUSETTS, INC. (FKA AMRI BURLINGTON, INC.); CURIA WISCONSIN, INC. (FKA CEDARBURG PHARMACEUTICALS, INC.); CURIA INDIANA, LLC (FKA AMRI SSCI, LLC); CURIA NEW MEXICO, LLC (FKA OSO BIOPHARMACEUTICALS MANUFACTURING, LLC); CURIA IP HOLDINGS, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 057423/0665 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
Reel/Frame 054252/0687 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 7541537 PREVIOUSLY RECORDED AT REEL: 034045 FRAME: 0951. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
FIRST LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC-BY ITS SOLE MEMBER: ALO ACQUISITION LLC
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING LLC-BY ITS SOLE MEMBER:ALO ACQUISITION LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC; AMRI SSCI, LLC; EUTICALS INC.
Reel/Frame 043742/0085 →
SECURITY INTEREST Recorded Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI RENESSELAER, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 028078/0227 →
TERMINATION Recorded Apr 19, 2012
From: BANK OF AMERICA, N.A.
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.; AMRI RENESSELAER, INC.
Reel/Frame 028072/0335 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 6, 2011
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI RENSSELAER, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026397/0001 →
MERGER Recorded Feb 8, 2010
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023905/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2009
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 022092/0512 →